Clariant AG (CLN.SW)
Muttenz, CH
Clariant AG operates as a global leader in specialty chemicals, organized into three primary business units: Care Chemicals, Catalysis, and Natural Resources. The company develops and supplies a broad spectrum of chemical products and solutions. This includes fire retardants, performance-enhancing additives, and advanced surface treatments for applications spanning plastics, coatings, inks, and consumer goods. It also provides essential catalysts for petrochemical and fuel refining, synthesis gas, general chemical processes, and emissions control, along with specialized zeolite and custom catalyst solutions. Clariant further manufactures specialized bentonite-based products, serving diverse sectors such as oil purification, foundries, animal feed, civil construction, wastewater treatment, and various industrial uses including paper, detergents, and PVC stabilization. Its extensive portfolio also features industrial and consumer specialty chemicals and tailored application solutions across numerous markets. These encompass automotive fluids (like brake fluids and coolants), aircraft de-icing, construction chemicals, agrochemicals, food ingredients, gas processing, heat transfer, home and industrial cleaning, lubricant additives, specialized solvents, paints and coatings, healthcare, and personal care ingredients. Additionally, the company offers sophisticated oilfield production chemicals for enhanced oil recovery, offshore and unconventional drilling, paraffin control, and well services, complemented by its intelligent chemical management system, Veritrax. Clariant also provides comprehensive chemical solutions for the mining industry, additives for refinery services, and develops biofuels and their derivatives, exemplified by sunliquid, which transforms agricultural residues into cellulosic ethanol. Its product range extends to organic, inorganic, and anti-corrosive pigments, as well as pigment preparations, dyes, and specialty materials vital for coatings, plastics, conventional and digital printing, textiles, and personal care applications. Founded in 1886, Clariant AG is headquartered in Muttenz, Switzerland.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.99% | -0.31% | -0.31% | -4.80% | +10.23% | +12.87% | -13.43% | -40.02% | -58.74% | -54.51% | -61.12% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | +1 |
| Buy | 3 | 0 |
| Hold | 10 | +1 |
| Sell | 2 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-5.7% Q4'25: -7.6% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%-131.1% Q4'25: -34.8% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.3% Q4'25: +10.4% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+10.2% ★ Q4'25: +9.4% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+6.4% ★ Q4'25: +19.4% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%-1.3% ★ Q4'25: -0.6% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.33× Q4'25: 1.74× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 10 EPS Ana. |
Dec 2027 15 Rev. Ana. 11 EPS Ana. |
Dec 2028 12 Rev. Ana. 4 EPS Ana. |
Dec 2029 11 Rev. Ana. 2 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.31B
est.
|
9.33B
est: 9.48B (-1.6%)
|
8.52B
est: 8.56B (-0.6%)
|
8.53B
est: 8.61B (-0.9%)
|
7.73B
est: 8.25B (-6.3%)
|
8.10B
est: 8.35B (-2.9%)
|
8.53B
est: 8.62B (-1.0%)
|
8.07B
est: 8.34B (-3.2%)
|
6.61B
est: 6.74B (-1.9%)
|
7.12B
est: 7.21B (-1.2%)
|
7.37B
est: 7.43B (-0.7%)
|
6.04B
est: 7.91B (-23.7%)
|
6.08B
est: 6.12B (-0.8%)
|
6.12B
est: 6.22B (-1.7%)
|
5.81B
est: 5.78B (+0.4%)
|
5.85B
est: 5.88B (-0.5%)
|
6.38B
est: 6.33B (+0.7%)
|
6.62B
est: 6.71B (-1.3%)
|
4.40B
est: 4.54B (-3.1%)
|
3.86B
est: 3.84B (+0.5%)
|
4.37B
est: 4.33B (+1.0%)
|
5.20B
est: 5.18B (+0.3%)
|
4.38B
est: 4.16B (+5.1%)
|
4.15B
est: 4.14B (+0.3%)
|
3.92B
est: 3.92B (0.0%)
|
3.83B
3.74B – 3.92B
-2.3% YoY
|
3.95B
3.79B – 4.23B
+3.2% YoY
|
4.06B
4.06B – 4.06B
+2.8% YoY
|
4.10B
3.97B – 4.30B
+0.9% YoY
|
4.22B
4.09B – 4.42B
+3.0% YoY
|
| EBITDA |
1.16B
est.
|
1.29B
est: 806.49M (+60.3%)
|
1.38B
est: 625.19M (+120.6%)
|
744.00M
est: 593.14M (+25.4%)
|
766.00M
est: 449.22M (+70.5%)
|
663.00M
est: 502.79M (+31.9%)
|
587.00M
est: 249.95M (+134.8%)
|
421.00M
est: 301.80M (+39.5%)
|
177.00M
est: 164.72M (+7.5%)
|
880.00M
est: 2.14M (+41,034.9%)
|
663.00M
est: 340.91M (+94.5%)
|
701.00M
est: 439.16M (+59.6%)
|
780.00M
est: 307.86M (+153.4%)
|
792.00M
est: 170.66M (+364.1%)
|
773.00M
est: 408.00M (+89.5%)
|
780.00M
est: 399.60M (+95.2%)
|
853.00M
est: 479.72M (+77.8%)
|
667.00M
est: 748.77M (-10.9%)
|
497.00M
est: 438.24M (+13.4%)
|
571.00M
est: 318.10M (+79.5%)
|
723.00M
est: 334.89M (+115.9%)
|
337.00M
est: 346.04M (-2.6%)
|
510.00M
est: 566.48M (-10.0%)
|
696.00M
est: 563.24M (+23.6%)
|
650.00M
est: 532.93M (+22.0%)
|
520.91M
509.52M – 533.81M
-2.3% YoY
|
537.42M
515.68M – 575.54M
+3.2% YoY
|
552.51M
552.00M – 553.02M
+2.8% YoY
|
557.57M
540.11M – 584.48M
+0.9% YoY
|
574.38M
556.39M – 602.09M
+3.0% YoY
|
| EBIT |
1.05B
est.
|
-102.00M
est: -800.10M (+87.3%)
|
819.00M
est: -182.50M (+548.8%)
|
359.00M
est: 561.98M (-36.1%)
|
483.00M
est: 513.12M (-5.9%)
|
418.00M
est: 370.80M (+12.7%)
|
309.00M
est: 397.64M (-22.3%)
|
246.00M
est: 268.91M (-8.5%)
|
-48.00M
est: 185.82M (-125.8%)
|
675.00M
est: -21.39M (+3,255.2%)
|
414.00M
est: 376.96M (+9.8%)
|
421.00M
est: 540.43M (-22.1%)
|
499.00M
est: 306.31M (+62.9%)
|
508.00M
est: 477.44M (+6.4%)
|
404.00M
est: 492.42M (-18.0%)
|
447.00M
est: 505.61M (-11.6%)
|
530.00M
est: 544.61M (-2.7%)
|
369.00M
est: 526.79M (-30.0%)
|
167.00M
est: 226.94M (-26.4%)
|
302.00M
est: 145.79M (+107.1%)
|
456.00M
est: 153.49M (+197.1%)
|
61.00M
est: 158.60M (-61.5%)
|
274.00M
est: 323.41M (-15.3%)
|
449.00M
est: 321.56M (+39.6%)
|
398.00M
est: 304.26M (+30.8%)
|
297.39M
290.89M – 304.76M
-2.3% YoY
|
306.82M
294.41M – 328.58M
+3.2% YoY
|
315.43M
315.14M – 315.73M
+2.8% YoY
|
318.32M
308.36M – 333.68M
+0.9% YoY
|
327.92M
317.65M – 343.74M
+3.0% YoY
|
| Net Income |
524.00M
est.
|
-639.00M
est: -1.13B (+43.6%)
|
173.00M
est: -585.44M (+129.6%)
|
152.00M
est: 161.86M (-6.1%)
|
184.00M
est: 145.22M (+26.7%)
|
-85.00M
est: 185.40M (-145.8%)
|
5.00M
est: -87.79M (+105.7%)
|
-37.00M
est: -1.93M (-1,812.5%)
|
-206.00M
est: -36.51M (-464.2%)
|
191.00M
est: -220.35M (+186.7%)
|
227.00M
est: 185.39M (+22.4%)
|
217.00M
est: 241.97M (-10.3%)
|
-20.00M
est: 167.85M (-111.9%)
|
152.00M
est: -20.32M (+848.2%)
|
229.00M
est: 142.57M (+60.6%)
|
253.00M
est: 233.44M (+8.4%)
|
277.00M
est: 269.11M (+2.9%)
|
337.00M
est: 294.20M (+14.5%)
|
-34.00M
est: 219.77M (-115.5%)
|
116.00M
est: 8.84M (+1,212.8%)
|
344.00M
est: 9.30M (+3,597.9%)
|
-101.00M
est: -98.00M (-3.1%)
|
134.00M
est: 118.00M (+13.6%)
|
244.00M
est: 270.26M (-9.7%)
|
-75.00M
est: 230.71M (-132.5%)
|
210.25M
190.07M – 277.06M
-8.9% YoY
|
263.22M
230.62M – 321.81M
+25.2% YoY
|
254.03M
241.84M – 320.04M
-3.5% YoY
|
300.00M
287.79M – 318.82M
+18.1% YoY
|
260.87M
250.25M – 277.24M
-13.0% YoY
|
| SGA |
2.22B
est.
|
669.00M
est: 1.90B (-64.8%)
|
547.00M
est: 1.85B (-70.5%)
|
561.00M
est: 1.85B (-69.7%)
|
374.00M
est: 1.77B (-78.8%)
|
394.00M
est: 1.72B (-77.1%)
|
391.00M
est: 1.78B (-78.0%)
|
421.00M
est: 1.72B (-75.5%)
|
1.47B
est: 1.33B (+10.7%)
|
1.18B
est: 1.57B (-25.1%)
|
1.18B
est: 1.21B (-3.0%)
|
1.11B
est: 1.25B (-11.1%)
|
1.03B
est: 861.69M (+20.0%)
|
1.05B
est: 1.05B (-0.1%)
|
1.06B
est: 983.90M (+8.1%)
|
1.14B
est: 1.08B (+4.9%)
|
1.30B
est: 1.13B (+14.6%)
|
1.31B
est: 1.21B (+8.0%)
|
1.07B
est: 523.01M (+104.6%)
|
747.00M
est: 705.11M (+5.9%)
|
741.00M
est: 742.34M (-0.2%)
|
834.00M
est: 767.05M (+8.7%)
|
709.00M
est: 708.86M (+0.0%)
|
748.00M
est: 704.80M (+6.1%)
|
702.00M
est: 666.88M (+5.3%)
|
651.83M
637.58M – 667.98M
-2.3% YoY
|
672.49M
645.29M – 720.19M
+3.2% YoY
|
691.37M
690.73M – 692.01M
+2.8% YoY
|
697.71M
675.86M – 731.38M
+0.9% YoY
|
718.74M
696.23M – 753.42M
+3.0% YoY
|
| EPS |
-5.70
est.
|
-4.23
est: 1.17 (-461.2%)
|
1.08
est: 0.80 (+34.2%)
|
0.72
est: 1.06 (-32.3%)
|
0.81
est: 1.37 (-40.8%)
|
-0.37
est: 1.48 (-125.1%)
|
-0.01
est: 1.35 (-100.7%)
|
-0.16
est: 1.30 (-112.3%)
|
-0.91
est: 0.20 (-545.7%)
|
0.81
est: 1.71 (-52.7%)
|
0.86
est: 1.26 (-31.6%)
|
0.74
est: 0.97 (-23.4%)
|
-0.06
est: 1.07 (-106.0%)
|
0.48
est: 1.08 (-55.7%)
|
0.71
est: 0.86 (-17.9%)
|
0.78
est: 0.96 (-18.7%)
|
0.84
est: 1.05 (-20.4%)
|
1.02
est: 1.18 (-13.2%)
|
-0.10
est: 0.82 (-112.2%)
|
0.35
est: 0.57 (-38.6%)
|
1.04
est: 0.92 (+13.4%)
|
-0.31
est: 0.96 (-132.3%)
|
0.41
est: 0.36 (+14.3%)
|
0.74
est: 0.82 (-9.7%)
|
-0.23
est: 0.70 (-133.0%)
|
0.70
0.58 – 0.85
+0.4% YoY
|
0.83
0.71 – 0.99
+19.1% YoY
|
0.90
0.74 – 0.98
+7.8% YoY
|
0.92
0.88 – 0.98
+2.4% YoY
|
0.80
0.77 – 0.85
-13.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi Global Bioenergy UCITS ETF EUR Acc CWE.PA | 1.79% | 1.26M | 0.35% |
| 2 | Amundi Global Bioenergy UCITS ETF USD Acc CWEU.L | 1.79% | 1.26M | 0.35% |
| 3 | iShares SMIM ETF (CH) CSSMIM.SW | 0.55% | 8.21M | 0.45% |
| 4 | Inspire International ETF WWJD | 0.51% | 2.72M | 0.61% |
| 5 | WisdomTree International SmallCap Dividend Fund DLS | 0.33% | 3.44M | 0.58% |
| 6 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.33% | 1.41M | 0.48% |
| 7 | WisdomTree Europe Equity Income UCITS ETF Acc EEIA.L | 0.32% | 761.3K | 0.29% |
| 8 | WisdomTree Europe Equity Income UCITS ETF WTEE.DE | 0.32% | 761.3K | 0.29% |
| 9 | Inspire Global Hope ETF BLES | 0.26% | 406.6K | 0.60% |
| 10 | Dimensional - International Small Cap Value ETF DISV | 0.22% | 10.63M | 0.42% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Conrad Keijzer | Chief Executive Officer | 4M | male |
| Chris Hansen | Chief Corporate Development Officer | — | male |
| Joachim Krüger | Head of Corporation Sustainability & Regulatory Affairs | — | male |
| Judith Bischoff | General Counsel & Head of Group Legal Services | — | — |
| Kai Rolker | Head of Group Communications | — | — |
| Monica Ferreira | Region Head of Latin America | — | — |
| Oliver Rittgen | Chief Financial Officer | — | male |
| Priya Thaman | Chief Human Resources Officer | — | — |
| Andreas Schwarzwaelder | Head of Investor Relations | — | male |
| Richard Haldimann | Chief Strategy & Technology Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CLN.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
